BACKGROUND:Electromyographic biofeedback (EMG-BFB) has shown equivocal benefits on gait retraining after stroke. OBJECTIVE: The authors evaluated the efficacy of EMG-BFB applied in a task-oriented approach based on principles of motor learning to increase peak ankle power of the affected leg and gait velocity in patients with chronic mild to moderate hemiparesis. METHODS: They assigned 20 participants randomly to the EMG-BFB group or a control group that received conventional therapy for the same duration. Quantitative gait analysis was performed before and after treatment. The EMG-BFB involved the triceps surae during functional gait activities. Treatment was administered with a fading frequency of BFB application and an increasing variability in gait activities. Both groups had 20 treatment sessions of 45 minutes each, including at least 15 minutes of walking-related therapy for the control group. Follow-up (FU) gait analysis was obtained 6 weeks after training. RESULTS:BFB treatment led to significant increases (P < .01) in peak ankle power at push-off (from 0.63 W/kg to 1.04 W/kg) in conjunction with significant increases in velocity (from 28.3 %h/s--normalized to percentage height per second--to 39.6 %h/s) and stride length (from 44.5 %h--normalized to percentage height--to 57.6 %h). Increases remained significant at FU. There were no changes in any gait variable in the control group. CONCLUSION: A task-oriented BFB treatment was effective in increasing peak ankle power, gait velocity, and stride length in a population with hemiparesis. Further studies should compare the combination intervention with either of its components in more impaired patients.
RCT Entities:
BACKGROUND: Electromyographic biofeedback (EMG-BFB) has shown equivocal benefits on gait retraining after stroke. OBJECTIVE: The authors evaluated the efficacy of EMG-BFB applied in a task-oriented approach based on principles of motor learning to increase peak ankle power of the affected leg and gait velocity in patients with chronic mild to moderate hemiparesis. METHODS: They assigned 20 participants randomly to the EMG-BFB group or a control group that received conventional therapy for the same duration. Quantitative gait analysis was performed before and after treatment. The EMG-BFB involved the triceps surae during functional gait activities. Treatment was administered with a fading frequency of BFB application and an increasing variability in gait activities. Both groups had 20 treatment sessions of 45 minutes each, including at least 15 minutes of walking-related therapy for the control group. Follow-up (FU) gait analysis was obtained 6 weeks after training. RESULTS:BFB treatment led to significant increases (P < .01) in peak ankle power at push-off (from 0.63 W/kg to 1.04 W/kg) in conjunction with significant increases in velocity (from 28.3 %h/s--normalized to percentage height per second--to 39.6 %h/s) and stride length (from 44.5 %h--normalized to percentage height--to 57.6 %h). Increases remained significant at FU. There were no changes in any gait variable in the control group. CONCLUSION: A task-oriented BFB treatment was effective in increasing peak ankle power, gait velocity, and stride length in a population with hemiparesis. Further studies should compare the combination intervention with either of its components in more impaired patients.
Authors: Lynne R Sheffler; Paul N Taylor; Stephanie Nogan Bailey; Douglas D Gunzler; Jaap H Buurke; Maarten J IJzerman; John Chae Journal: Am J Phys Med Rehabil Date: 2015-05 Impact factor: 2.159
Authors: Katlin Genthe; Christopher Schenck; Steven Eicholtz; Laura Zajac-Cox; Steven Wolf; Trisha M Kesar Journal: Top Stroke Rehabil Date: 2018-02-19 Impact factor: 2.119
Authors: Steven C Cramer; Mriganka Sur; Bruce H Dobkin; Charles O'Brien; Terence D Sanger; John Q Trojanowski; Judith M Rumsey; Ramona Hicks; Judy Cameron; Daofen Chen; Wen G Chen; Leonardo G Cohen; Christopher deCharms; Charles J Duffy; Guinevere F Eden; Eberhard E Fetz; Rosemarie Filart; Michelle Freund; Steven J Grant; Suzanne Haber; Peter W Kalivas; Bryan Kolb; Arthur F Kramer; Minda Lynch; Helen S Mayberg; Patrick S McQuillen; Ralph Nitkin; Alvaro Pascual-Leone; Patricia Reuter-Lorenz; Nicholas Schiff; Anu Sharma; Lana Shekim; Michael Stryker; Edith V Sullivan; Sophia Vinogradov Journal: Brain Date: 2011-04-10 Impact factor: 13.501
Authors: Reza Koiler; Elham Bakhshipour; Joseph Glutting; Amy Lalime; Dexter Kofa; Nancy Getchell Journal: Int J Environ Res Public Health Date: 2021-06-15 Impact factor: 3.390